Akihiko Ozaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Akihiko Ozaki has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
K. Wakabayashi
Toshiba Corporation, 1-6 Uchisaiwai-cho 1-chome, Chiyoda-ku, Tokyo 100, Japan
1 shared publicationM. Seki
Japan Atomic Energy Research Institute, Naka Fusion Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-01, Japan
1 shared publicationS. Maebara
Japan Atomic Energy Research Institute, Naka Fusion Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-01, Japan
1 shared publication- Satoru Asai
DAIHEN Welding and Joining Research Alliance Laboratories, Joining and Welding Research Institute, The University of Osaka, Osaka 567-0047, Japan
1 shared publication - Takafumi Wada
Department of Neurology, Graduate School of Medicine Kyoto University Kyoto Japan
1 shared publication Toru Yamamoto
Department of Neurology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
1 shared publication
Latest Publications
- Open Access
- 6 October 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (3) , 389-395
Punctate Enhancement of Bilateral Basal Ganglia in a Case of Epstein-Barr Virus Encephalitis
Epstein-Barr virus (EBV) encephalitis is caused by initial infection or reactivation of EBV. In adults, the risk factors of EBV encephalitis include human immunodeficiency virus infection, immunosuppressant drugs, congenital immune deficiencies, post-stem cell transplantation, and post-solid organ transplantation. However, a few cases of adult-onset EBV encephalitis without these risk factors were also reported. The efficacy of steroid or intravenous immunoglobulin remains unclear in the treatment of EBV encephalitis. Herein, we report a case of an 82-year-old man with fever and disturbance of consciousness who was diagnosed as having EBV encephalitis. Gadolinium-enhanced magnetic resonance imaging showed punctate enhancement in the bilateral basal ganglia, which resembled chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Symptoms and enhanced lesions improved after immunotherapy. Immunotherapy may be effective in the treatment of EBV encephalitis with CLIPPERS-like lesions.
- 6 October 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (3) , 389-395
Open AccessPunctate Enhancement of Bilateral Basal Ganglia in a Case of Epstein-Barr Virus Encephalitis
Epstein-Barr virus (EBV) encephalitis is caused by initial infection or reactivation of EBV. In adults, the risk factors of EBV encephalitis include human immunodeficiency virus infection, immunosuppressant drugs, congenital immune deficiencies, post-stem cell transplantation, and post-solid organ transplantation. However, a few cases of adult-onset EBV encephalitis without these risk factors were also reported. The efficacy of steroid or intravenous immunoglobulin remains unclear in the treatment of EBV encephalitis. Herein, we report a case of an 82-year-old man with fever and disturbance of consciousness who was diagnosed as having EBV encephalitis. Gadolinium-enhanced magnetic resonance imaging showed punctate enhancement in the bilateral basal ganglia, which resembled chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Symptoms and enhanced lesions improved after immunotherapy. Immunotherapy may be effective in the treatment of EBV encephalitis with CLIPPERS-like lesions.
- 1 October 1993
- Published by Elsevier in Fusion Engineering and Design
- Vol. 23 (1) , 33-42
Development of a diffusion bonding method for fabrication of lower hybrid current drive grills
- 1 October 1993
- Published by Elsevier in Fusion Engineering and Design
- Vol. 23 (1) , 33-42
Development of a diffusion bonding method for fabrication of lower hybrid current drive grills